LEXINGTON, KY, UNITED STATES, March 11, 2026 / EINPresswire.com / — The Child Neurology Foundation (CNF) today announced Ambry Genetics, now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), ...

The drug leucovorin was touted by the Trump administration in September as a potential treatment for thousands of children with autism. Now, some parents and guardians of children with autism say they ...

The scenarios keeping AI bosses awake at night are no longer purely hypothetical. The tech is being used in hacking, scamming, weapons and sabotage.

Investigational RGX-202 continues to demonstrate evidence of positively changing disease trajectory for Duchenne Pivotal dose participants exceeded external controls across functional ...